MagBioSense Inc.

A biotechnology platform developed to commercialize a novel cardiac biomarker diagnostic technology that brings lab-quality, high-sensitivity detection to the point-of-care.

Biotechnology
Active
St. Louis, United States Founded 2013
Website ↗
Last updated 2026-08-21
Total raised
—
Stage
—
Founded
2013
Headcount
—
HQ
St. Louis, United States
Sector
Biotechnology

About

MagBioSense is a private, medical device company focused on the development of a breakthrough high-sensitivity, diagnostic device for use at the point-of-care. The device will change how heart attacks are diagnosed in the Emergency Department by providing high-sensitivity detection of cardiac troponin I.

Q&A

What is MagBioSense Inc.'s primary focus?
MagBioSense Inc. is a medical device company focused on developing a breakthrough high-sensitivity diagnostic device for point-of-care use, specifically for detecting cardiac troponin I to diagnose heart attacks in Emergency Departments.
When was MagBioSense Inc. founded?
MagBioSense Inc. was founded in 2013.
Where is MagBioSense Inc. headquartered?
MagBioSense Inc. is headquartered in St. Louis, United States.
Who is a founder of MagBioSense Inc.?
Amos Danielli is a founder of MagBioSense Inc.
What is the primary sector of MagBioSense Inc.?
The primary sector of MagBioSense Inc. is Biotechnology.
What technology does MagBioSense Inc. specialize in?
MagBioSense Inc. specializes in cardiac biomarker diagnostic technology and point-of-care diagnostics, focusing on high-sensitivity detection of cardiac troponin I.

Team · 1

Amos Danielli
Founder · Founder

Sectors & technology

Primary sector
Biotechnology
Technologies
Target customers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)